PP25 Cushing Syndrome and Primary Adrenal Disorders

Program: Abstracts - Orals, Poster Previews, and Posters
Poster Session
Adrenal HPA Axis-Clinical/Translational
Sunday, April 3, 2016: 11:30 AM-11:45 AM
BR East (BCEC)
Chairs:
Andre Lacroix, MD, Centre hospitalier de l’Université de Montréal (CHUM), Université de Montréal, Montreal, Canada and Duarte Pignatelli, MD, PhD, Hospital S João, Porto, Portugal

Disclosures:
AL: Investigator, Novartis Pharmaceuticals, Editor, Up To Date, Advisory Group Member, EMD Serono, Advisory Group Member, Ipsen, Investigator, Strongbridge. Disclosure Not Provided: DP, GA
Christiaan F Mooij, Division of Pediatric Endocrinology, Amalia Children's Hospital, Radboud University Medical Center, Nijmegen, Netherlands, Antonius E Van Herwaarden, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, Netherlands, Nel Roeleveld, Amalia Children's Hospital, Radboud university medical center, Nijmegen, Netherlands, Chris L de Korte, Medical Ultrasound Imaging Center, Radboud university medical center, Nijmegen, Netherlands, Livia Kapusta, Pediatric Cardiology Unit, Dana-Dwek Children’s Hospital, Sourasky Medical Center, Tel Aviv, Israel and Hedi Claahsen-van der Grinten, Division of Pediatric Endocrinology, Amalia Children's Hospital, Radboud University Medical Centre, Nijmegen, Netherlands
Poster Board Number: SUN 426
Naomi Weintrob1, Ori Eyal, MD2, Anat Segev-Becker3, Irit Ayalon4, Anitav Schachter-Davidov3 and Asaf Oren3, (1)Tel Aviv Medical Center, Hod Hasharon, Israel
(2)Pediatric Endocrinology and Diabetes Unit, Dana-Dwek Children Hospital, Tel Aviv Sourasky Medical Center, Givatayim, Israel
(3)Tel Aviv Medical Center
(4)Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv
Poster Board Number: SUN 425
Rosario Pivonello, MD, PhD1, Giorgio Arnaldi, MD2, Carla Maria Scaroni, MD3, Carla Giordano4, Salvatore Cannavo, MD5, Davide Iacuaniello1, Laura Trementino2, Marialuisa Zilio3, Valentina Guarnotta4, Adriana Albani5, Alessia Cozzolino1, Grazia Michetti2, Marco Boscaro3 and Annamaria Colao, MD, PhD1, (1)Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Università Federico II, Naples, Italy
(2)Clinica di Endocrinologia e Malattie del Metabolismo, Ospedali Riuniti di Ancona, Ancona, Italy
(3)Dipartimento di Medicina, DIMED, Unità Operativa di Endocrinologia, Università di Padova, Padua, Italy
(4)Dipartimento Biomedico di Medicina Interna e Specialistica Di.Bi.MI.S, A.O.U.P. “Paolo Giaccone”, Palermo, Italy
(5)Dipartimento di Medicina Clinica e Sperimentale, Università di Messina, Messina, Italy
Poster Board Number: SUN 434
Oskar Ragnarsson, MD, PhD1, Andreas Stomby, MD, PhD2, Per Dahlqvist, MD, PhD3, Johan Arild Evang4, Mats Ryberg, MD, PhD3, Tommy Olsson, MD, PHD5, Jens Bollerslev, MD, DMSC4, Lars Nyberg, PhD6 and Gudmundur Johannsson, MD, PhD1, (1)Institute of Medicine at Sahlgrenska Academy, University of Gothenburg and The Department of Endocrinology, Sahlgrenska University Hospital, Göteborg, Sweden
(2)Region Jönköping County, Jönköping, Sweden
(3)Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden
(4)Section of Specialized Endocrinology, Oslo University Hospital-Rikshospitalet, Oslo, Norway
(5)Department of Public Health and Clinical Medicine, Division of Medicine, Umeå University, Umeå, Sweden
(6)Department of Radiation Sciences (Diagnostic Radiology) and Umeå center for Functional Brain Imaging, Umeå, Sweden
Poster Board Number: SUN 433

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire